Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Danaher Community
NYSE:DHR Community
1
Narratives
written by author
0
Comments
on narratives written by author
91
Fair Values set
on narratives written by author
Community Investing Ideas
Danaher
Popular
Undervalued
Overvalued
Danaher
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Advanced Diagnostics And Personalized Therapies Will Expand Global Markets
Key Takeaways Strong recurring revenue and margin stability are driven by consumables, services, and robust demand for advanced diagnostics and life science tools. Innovation in precision medicine and disciplined operational execution position the company for high-margin growth and expanding global market opportunities.
View narrative
US$245.95
FV
15.0% undervalued
intrinsic discount
6.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
53
users have followed this narrative
about 14 hours ago
author updated this narrative
Your Valuation for
DHR
DHR
Danaher
Your Fair Value
US$
Current Price
US$209.14
0.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
33b
2015
2018
2021
2024
2025
2027
2030
Revenue US$32.5b
Earnings US$4.6b
Advanced
Set Fair Value